Marisa Co, Bristol-Myers Squibb

Marisa Co


9:55 AM - 10:20 AM

Real-World Evidence and AI: Where are We Now and How Can We Take the Next Steps Forward to Directly Impact Care?

This session will focus on the kind of real world data that is needed to realize the potential of AI. With so much opportunity for progress, prioritizing projects is a critical step in delivering on results. Speakers will help identify what types of questions are easier to answer and which are harder in order to help you choose the projects that will result in near term ROI. Using case study examples from two therapeutic areas, discussion will cover these questions and more:  
  • What are the most reliable sources of real world data?
  • How does data need to be curated to be useful?
  • Where are we on the path to directly impacting care?
  • What needs to be done to get to the next phase in realizing the potential of AI through the use of real world evidence?


  • Mike Townsend

    Mike Townsend Research Manager, Life Sciences Commercial Strategies IDC Health Insights


  • Marisa Co

    Marisa Co Vice President R&D Business Insights & Analytics Bristol-Myers Squibb

Download Latest Agenda